- Fellowship - Mayo Clinic College of Medicine and Science (2009-2012), Endocrinology, Diabetes, Metabolism & Nutrition
- Residency - Mayo Clinic College of Medicine and Science (2007-2009), Internal Medicine
- Medical School - Royal College of Surgeons in Ireland (1998-2004)
- Fellowship - UT Southwestern Medical Center (2012-2013), Nutrition & Metabolic Diseases
- Residency - Mater Misericordiae University Hospital (2005-2007), Internal Medicine
- Internship - Beaumont Hospital (2004-2005), Internal Medicine
Jaime Almandoz, M.D.
- Internal Medicine - Endocrinology
- Bariatric/Weight Loss Surgery
Jaime Almandoz, M.D., is an Assistant Professor in UT Southwestern Medical Center’s Department of Internal Medicine, Division of Endocrinology, and he’s the Assistant Medical Director of the UTSW Clinical Research Unit in the Center for Translational Medicine. He is an expert in nonsurgical weight management and the medical care of patients following bariatric surgery.
Originally from the island nation of Trinidad in the Caribbean, Dr. Almandoz received his medical degree from the Royal College of Surgeons in Ireland. After graduating first in his class, he completed a residency in internal medicine at the Mater Misericordiae Hospital in Dublin, Ireland. He then spent time at the Mayo Clinic in Rochester, Minnesota, where he received further training in internal medicine and advanced fellowship training in endocrinology, diabetes, metabolism, and nutrition. He subsequently completed an additional fellowship in nutrition and metabolic diseases at UT Southwestern.
Triple board certified in internal medicine, endocrinology, and obesity medicine, Dr. Almandoz joined the UT Southwestern faculty in 2013. As a member of UT Southwestern’s Endocrinology team, he provides specialized care to patients seeking medical weight-loss therapies and to patients following bariatric surgery who have developed nutritional problems or weight regain. He also sees patients with cholesterol disorders and Type 2 diabetes.
Dr. Almandoz publishes the results of his work frequently in scientific and medical journals and is involved in a variety of professional organizations, including the Obesity Society, Endocrine Society, American Association of Clinical Endocrinologists, and American Diabetes Association.
Meet Dr. Almandoz
Weight management and metabolism specialist in Dallas
Jaime Almandoz, M.D., is an expert in nonsurgical weight management and the medical care of patients following bariatric surgery, a calling that fully utilizes his advanced training in internal medicine, endocrinology, and obesity medicine.
Dr. Almandoz is passionate about providing individualized, patient-centered care to improve metabolic health and overall wellness.
“Most of my patients have struggled with their weight for years, and many of them have lost hope instead of weight. One of my jobs is to help them effectively manage their weight and to treat the metabolic complications of obesity, such as Type 2 diabetes,” he says.
Dr. Almandoz sees a mix of patients, including those who don’t want bariatric surgery, those who are thinking about it, and those who have had it.
“I strive to ensure that they’re maximizing their weight-loss potential and are not becoming unwell or nutritionally deficient along the way,” he says.
Doing this successfully requires the specialized skills to identify each patient’s health concerns, preferences, and limitations to create a personalized and integrated approach.
“The cornerstone of weight loss is achieving a negative energy balance. We work with patients on novel methods for calorie tracking, dietary modification, weight loss medications, and meal replacement plans where necessary. Physical activity is also important, and we help patients begin safe and suitable exercise programs,” Dr. Almandoz says. “With the nation’s ever-growing obesity epidemic, the stakes could not be higher."
More than one-third of the American population is obese and, despite reports to the contrary, there is probably no such thing as “healthy obesity.” This is a concept that someone may be obese yet “metabolically healthy” – with normal blood pressure, cholesterol, and blood sugar. However, when these people are followed over time, they still have an increased risk of death and heart disease compared with people who weigh less. Excess body weight also increases the risk of other conditions such as cancer, obstructive sleep apnea, and osteoarthritis.
Triple board certified in internal medicine, endocrinology, and obesity medicine, Dr. Almandoz stays actively involved in clinical research as the Assistant Medical Director of UT Southwestern’s Clinical Research Unit.
“Weight management and metabolism is a fascinating field because it doesn’t just involves physiological pathways; there is also a significant social component,” he says.
“Human beings are complex organisms, and obesity is a complicated disease when you factor in environmental, genetic, and behavioral influences – things don’t always play by the rules. My role is to ensure that there are no metabolic problems or medications contributing to a patient’s weight problem, and to incorporate lifestyle changes, behavioral treatments, and medications or surgical therapies – whatever is needed to achieve success for every patient.”
- D Magazine Best Doctor 2020
- Captain Massey-Miles Prize in Obstetrics & Gynecology 2004, Medical School Graduation
- Mahon Medal in Medicine 2004, Medical School Graduation
- Wheeler Medal in Surgery 2004, Medical School Graduation
- Rueben Harvey Prize from the Royal College of Physicians and Surgeons, Dublin, Ireland 2004, Graduating first in medical school class
Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis.
Hazem A, Elamin MB, Bancos I, Malaga G, Prutsky G, Domecq JP, Elraiyah TA, Abu Elnour NO, Prevost Y, Almandoz JP, Zeballos-Palacios C, Velasquez ER, Erwin PJ, Natt N, Montori VM, Murad MH European journal of endocrinology / European Federation of Endocrine Societies 2012 Jan 166 1 13-20
Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis.
Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ, Lane MA, Liu H, Erwin PJ, Hensrud DD, Montori VM The Journal of clinical endocrinology and metabolism 2011 Oct 96 10 2997-3006
Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis.
Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH, Montori VM The Journal of clinical endocrinology and metabolism 2011 Jul 96 7 1931-42
Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans.
Nelson RH, Mundi MS, Vlazny DT, Smailovic A, Muthusamy K, Almandoz JP, Singh E, Jensen MD, Miles JM Diabetes 2013 Mar 62 3 783-8
Spillover of Fatty acids during dietary fat storage in type 2 diabetes: relationship to body fat depots and effects of weight loss.
Almandoz JP, Singh E, Howell LA, Grothe K, Vlazny DT, Smailovic A, Irving BA, Nelson RH, Miles JM Diabetes 2013 Jun 62 6 1897-903
Hypothyroidism: etiology, diagnosis, and management.
Almandoz JP, Gharib H The Medical clinics of North America 2012 Mar 96 2 203-21
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy.
Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N Diabetes, metabolic syndrome and obesity : targets and therapy 2017 10 393-402
Impact of COVID-19 Stay-at-Home Orders on Weight-Related Behaviors Among Patients with Obesity.
Almandoz JP, Xie L, Schellinger JN, Mathew MS, Gazda C, Ofori A, Kukreja S, Messiah SE, Clinical obesity 2020 Jun e12386
Sleeve Gastrectomy for Weight Loss.
Puzziferri N, Almandoz JP JAMA 2018 01 319 3 316
Impact of bariatric surgery on cerebral vascular reactivity and cognitive function: a non-randomized pilot study.
Tucker WJ, Thomas BP, Puzziferri N, Samuel TJ, Zaha VG, Lingvay I, Almandoz J, Wang J, Gonzales EA, Brothers RM, Nelson MD, Pilot and feasibility studies 2020 6 21
- Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis.
- Metabolic syndrome in people of normal weight
- Atypical type 2 diabetes, e.g. in young or normal weight people
- Dietary fat storage
- Effects of weight loss on metabolism
- Metabolic complications of obesity
- Bariatric/Weight Loss Surgery